Primary outcomes: immunologic effects in tumor and peripheral blood mononuclear cells Secondary Outcomes: HPV E2, E7, CD8+ T-cells, FoxP3+ T-regulatory Cells. This evidence concerns the gene FOXP3 and neoplasm.